Sanofi (SNY) Shares Outstanding (Weighted Average) (2016 - 2025)

Sanofi (SNY) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 6.23% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 6.23% year-over-year, with the annual reading at $1.4 billion for FY2025, 1.8% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $1.4 billion in Q4 2025 for Sanofi, up from $1.3 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.4 billion in Q4 2021 to a low of $1.3 billion in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.4 billion across 5 years, with a median of $1.3 billion in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 10.86% in 2022 and later rose 6.23% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.4 billion in 2021, then fell by 10.86% to $1.3 billion in 2022, then grew by 5.44% to $1.3 billion in 2023, then fell by 0.71% to $1.3 billion in 2024, then rose by 6.23% to $1.4 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SNY at $1.4 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.3 billion in Q4 2023.